| 000 | 01655 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514155321.0 | ||
| 264 | 0 | _c20031017 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/cncr.11652 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoonla, Chanchai | |
| 245 | 0 | 0 |
_aPrognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. _h[electronic resource] |
| 260 |
_bCancer _cOct 2003 |
||
| 300 |
_a1438-43 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aBile Duct Neoplasms _xblood |
| 650 | 0 | 4 | _aBile Ducts, Intrahepatic |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xblood |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMucin 5AC |
| 650 | 0 | 4 |
_aMucins _xblood |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aWongkham, Sopit | |
| 700 | 1 | _aSheehan, John Kieran | |
| 700 | 1 | _aWongkham, Chaisiri | |
| 700 | 1 | _aBhudhisawasdi, Vajarabhongsa | |
| 700 | 1 | _aTepsiri, Nisana | |
| 700 | 1 | _aPairojkul, Chawalit | |
| 773 | 0 |
_tCancer _gvol. 98 _gno. 7 _gp. 1438-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.11652 _zAvailable from publisher's website |
| 999 |
_c14269705 _d14269705 |
||